Coronavirus update: Questions over Covid-19 vaccine efficacy rates, vaccination challenges before India

Coronavirus update: Questions over Covid-19 vaccine efficacy rates, vaccination challenges before India

India needs an affordable vaccine that can be manufactured in large quantities and delivered hasslefree, Dr. Kang said. (Reuters image) Coronavirus Covid-19 Vaccine update: As the world is inching closer to get the much elusive Coronavirus vaccine, we assess the announcements made by Pfizer-BioNTech and Moderna regarding their Covid-19 vaccine candidates, BNT162b2 and mRNA-1273, respectively. … Read more

How far we are from Coronavirus vaccine? Latest status of Pfizer, Covaxin, Oxford-AstraZeneca, Moderna Covid19 vaccines

How far we are from Coronavirus vaccine? Latest status of Pfizer, Covaxin, Oxford-AstraZeneca, Moderna Covid19 vaccines

Coronavirus, Covid-19 vaccine update: Albert Bourla revealed that a median of two months of safety data following the second and final dose of the Pfizer vaccine candidate will be available by the third week of November. (Reuters image) Coronavirus, Covid-19 vaccine update: Coronavirus has infected over 5.20 crore people and killed more than 12 lakh … Read more

Covid-19 vaccine: 3rd vaccine in pipeline, Russia approves 2nd vaccine EpiVacCorona; Check details

Covid-19 vaccine: 3rd vaccine in pipeline, Russia approves 2nd vaccine EpiVacCorona; Check details

Coronavirus Covid 19 vaccine update: The Russian government is also planning to grant approval to the third Coronavirus vaccine candidate. (Reuters image) Coronavirus Covid19 vaccine latest update: Russia has approved its second experimental vaccine for Coronavirus. The vaccine named as ‘EpiVacCorona’ has been given the much-required registration, President Vladimir Putin has announced. This has come … Read more